-transparent.png){kind=logo}
Eighteen patients with osteosarcoma, most of whom were adolescents, were examined for abnormalities of the brain by use of computed axial tomography. These studies were performed at 15-60 months (median 47 months) after the completion of adjuvant chemotherapy, which included high-dose methotrexate, cyclophosphamide, and Adriamycin. No abnormalities were found. The results of this study, together with the absence of brain lesions in published reports in children receiving high-dose methotrexate but no cranial irradiation, indicate that delayed neurotoxicity is not a major complication of this form of therapy in older children.
Related Publications
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
October 2014,
Current oncology (Toronto, Ont.),
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
May 2004,
Cancer,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
January 1987,
Klinische Padiatrie,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
January 1978,
Medicina,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
March 1979,
Cancer treatment reports,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
December 2001,
The Annals of pharmacotherapy,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
December 2008,
The Lancet. Oncology,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
August 1994,
Journal of internal medicine,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
August 1979,
The British journal of radiology,
D Bowles, and
C Pratt, and
W Evans, and
R A Price, and
T Coburn
October 2015,
The pharmacogenomics journal,
